361 Capital’s Athenahealth, Inc. ATHN Stock Holding History

361 Capital’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,834	Closed	-$834K	–	436
2018 Q1	$834K	Buy	+5,834	New	+$797K	0.21%	224
2017 Q2	–	Sell	-66,818	Closed	-$7.53M	–	227
2017 Q1	$7.53M	Sell	66,818 -401	-0.6%	-$46.7K	1.61%	16
2016 Q4	$7.07M	Buy	+67,219	New	+$7.23M	1.68%	17

Other funds holding ATHN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

361 Capital's ATHN Position: Q2 2018 in Review

361 Capital sold out of Athenahealth, Inc. (ATHN) in Q2 2018, closing a stake of 5,834 shares — an estimated $834K sold.

361 Capital first reported a position in ATHN in Q4 2016 and held it in 3 quarters. The position peaked at $7.53M in Q1 2017. 275 funds tracked by Wall St. Rank hold ATHN as of Q2 2018.

361 Capital reported no remaining Athenahealth, Inc. position as of Q2 2018 after selling out during the quarter.
361 Capital sold 5,834 Athenahealth, Inc. shares in Q2 2018, an estimated $834K.
361 Capital first reported a position in Athenahealth, Inc. in Q4 2016 and held it in 3 quarters.
361 Capital's Athenahealth, Inc. position peaked at $7.53M in Q1 2017.
275 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q2 2018.

Based on 361 Capital's 13F filing for Q2 2018, filed 14 Aug 2018.